Cargando…

The Use of Thromboelastography in Percutaneous Coronary Intervention and Acute Coronary Syndrome in East Asia: A Systematic Literature Review

Dual antiplatelet therapy (DAPT), alongside percutaneous coronary intervention (PCI), is central to the prevention of ischemic events following acute coronary syndrome (ACS). However, response to therapy can vary due to several factors including CYP2C19 gene variation, which shows increased prevalen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Ou, Hartmann, Jan, Tang, Yi-Da, Dias, Joao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267871/ https://www.ncbi.nlm.nih.gov/pubmed/35806936 http://dx.doi.org/10.3390/jcm11133652

Ejemplares similares

Antithrombotic Therapy After Acute Coronary Syndromes or Percutaneous Coronary Interventions in East Asian Populations
por: Kwon, Osung, et al.
Publicado: (2022)

Appropriateness of Percutaneous Coronary Interventions: A Systematic Review and Meta-Analysis
por: Liu, Yijie, et al.
Publicado: (2023)

Safety and Efficacy of Ticagrelor versus Clopidogrel in East Asian Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Treated with Dual Antiplatelet Therapy: A Meta-Analysis of Randomized Controlled Trials
por: Li, Jingyuan, et al.
Publicado: (2023)

Comparison of Six Different Percutaneous Coronary Intervention Guidance Modalities
por: Hu, Mengjin, et al.
Publicado: (2022)

Use of Thromboelastography in the Evaluation and Management of Patients With Traumatic Brain Injury: A Systematic Review and Meta-Analysis
por: Cannon, Jeremy W., et al.
Publicado: (2021)

Association Between Thromboelastography and Coronary Heart Disease
por: Yang, Liuqiao, et al.
Publicado: (2022)

Implications of bleeding in acute coronary syndrome and percutaneous coronary intervention
por: Pham, Phuong-Anh, et al.
Publicado: (2011)

Percutaneous coronary intervention in patients with acute coronary syndrome: focus on bivalirudin
por: Ramana, Ravi K, et al.
Publicado: (2008)

A Systematic Review on Bleeding Risk Scores’ Accuracy after Percutaneous Coronary Interventions in Acute and Elective Settings
por: Brinza, Crischentian, et al.
Publicado: (2021)

The Optimal Strategy of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Drug-Eluting Stent
por: Hu, Mengjin, et al.
Publicado: (2022)

Percutaneous Coronary Intervention Outcomes in Patients with Liver Cirrhosis: A Systematic Review and Meta-Analysis
por: Khandait, Harshwardhan, et al.
Publicado: (2023)

Antithrombotic Strategy for Patients with Acute Coronary Syndrome: A Perspective from East Asia
por: Numasawa, Yohei, et al.
Publicado: (2020)

Antithrombotic strategies in patients undergoing percutaneous coronary intervention for acute coronary syndrome
por: Pham, Son V, et al.
Publicado: (2010)

Percutaneous Intervention of a Single Coronary Artery in the Setting of Acute Coronary Syndrome
por: Shahin, Mohammady, et al.
Publicado: (2017)

Depression and Anxiety in patients undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome
por: Mujtaba, Syed Fayaz, et al.
Publicado: (2020)

Acute Coronary Syndrome Treated with Percutaneous Coronary Intervention in Hutchinson–Gilford Progeria
por: De Simone, Luciano, et al.
Publicado: (2023)

Two-Year Outcomes after Left Main Coronary Artery Percutaneous Coronary Intervention in Patients Presenting with Acute Coronary Syndrome
por: Jia, Si-Da, et al.
Publicado: (2020)

Impact of Coronary Dominance on In-Hospital Outcomes after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome
por: Kuno, Toshiki, et al.
Publicado: (2013)

Multiple Life-threatening Coronary Artery Spasms after Percutaneous Coronary Intervention for Acute Coronary Syndrome
por: Sawai, Toshiki, et al.
Publicado: (2018)

The relationship between procedural volume and patient outcomes for percutaneous coronary interventions: a systematic review and meta-analysis
por: Walsh, Kieran A., et al.
Publicado: (2021)

Prognostic Value of Serum Total Bilirubin after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome
por: Tang, Chengchun, et al.
Publicado: (2019)

Effect of Previous Statin Therapy in Patients With Acute Coronary Syndrome and Percutaneous Coronary Intervention
por: Yun, Kyeong Ho, et al.
Publicado: (2011)

Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention
por: Norgard, Nicholas B, et al.
Publicado: (2009)

The Effects of Percutaneous Coronary Intervention on the Flow in Acute Coronary Syndrome Patients—Geometry in Focus
por: Racz, Agnes Orsolya, et al.
Publicado: (2022)

Long-term effects of baseline on-treatment platelet reactivity in patients with acute coronary syndrome and thrombocytopenia undergoing percutaneous coronary intervention
por: Liu, Ru, et al.
Publicado: (2022)

Procedural Success Prediction Scoring Systems Used in Percutaneous Coronary Interventions for Chronic Total Occlusions: A Systematic Evaluation
por: Brinza, Crischentian, et al.
Publicado: (2021)

AGTR1rs5186 Polymorphism Is Associated with the Risk of Restenosis after Percutaneous Coronary Intervention: A Meta-Analysis
por: Lv, Feng, et al.
Publicado: (2022)

Efficacy and safety of intracoronary epinephrine for the management of the no-reflow phenomenon following percutaneous coronary interventions: a systematic-review study
por: Jafari Afshar, Elmira, et al.
Publicado: (2023)

Intravascular Ultrasound Imaging–Guided Versus Coronary Angiography–Guided Percutaneous Coronary Intervention: A Systematic Review and Meta‐Analysis
por: Darmoch, Fahed, et al.
Publicado: (2020)

Neutrophil-derived microparticles are released into the coronary circulation following percutaneous coronary intervention in acute coronary syndrome patients
por: Martínez, Gonzalo J., et al.
Publicado: (2017)

Percutaneous Coronary Intervention versus Coronary Artery Bypass Graft in Acute Coronary Syndrome patients with Renal Dysfunction
por: Zhang, Xiaojia, et al.
Publicado: (2018)

Efficacy and Safety of Different Courses of Tongxinluo Capsule as Adjuvant Therapy for Coronary Heart Disease after Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Hui, Jiaqi, et al.
Publicado: (2022)

Successful Percutaneous Coronary Intervention for Acute Coronary Syndrome in a Patient With Severe Hemophilia A
por: Kim, Dong-Kie, et al.
Publicado: (2010)

Selecting the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary intervention
por: Parikh, Shailja V, et al.
Publicado: (2009)

Percutaneous coronary intervention in acute coronary syndrome complicated by states Killip 3 and 4 in 2005
por: Zima, E, et al.
Publicado: (2007)

Usefulness of SYNTAX score II in complex percutaneous coronary interventions in the setting of acute coronary syndrome
por: Salvatore, Azzarelli, et al.
Publicado: (2016)

Clinical effect of ticagrelor administered in acute coronary syndrome patients following percutaneous coronary intervention
por: LU, YANJIAO, et al.
Publicado: (2016)

Acute coronary syndrome in octogenarians: association between percutaneous coronary intervention and long-term mortality
por: Barywani, Salim Bary, et al.
Publicado: (2015)

Intracoronary administration of tirofiban during percutaneous coronary intervention facilitates patients with acute coronary syndrome
por: Jia, Helei, et al.
Publicado: (2017)

Dynamic changes in purine catabolism in patients with acute coronary syndrome that underwent percutaneous coronary intervention
por: Visternichan, Olga, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_djopsapjmt7urert0vvmverv8n